SunWay Biotech Co., LTD. (1271.TWO)
TWD 82.5
(-0.6%)
TWD 82.5
(-0.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 55.98 Million | 42.58 Million | 160.75 Million | 181.86 Million | - |
| Net Income | 54.27 Million | 39.62 Million | 170.2 Million | 125.69 Million | - |
| Depreciation & Amortization | 27.1 Million | 7.75 Million | 19.73 Million | 20.33 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 133 Thousand | 289 Thousand | 228 Thousand | 128 Thousand |
| Change in working capital | -14.26 Million | -1.59 Million | -30.05 Million | 35.49 Million | - |
| Other non-cash items | 585 Thousand | 923 Thousand | 32 Thousand | 151 Thousand | - |
| Investing Cash Flow | 218.77 Million | -3.48 Million | -10.85 Million | -2.21 Million | - |
| Investments in PPE | -46.23 Million | -2.59 Million | -9.79 Million | -1.7 Million | - |
| Acquisitions | 293.22 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 5 Million |
| Other Investing Activities | -28.21 Million | -1.96 Million | -1.06 Million | -505 Thousand | - |
| Financing Cash Flow | -35.45 Million | -5.33 Million | -98.4 Million | 50.31 Million | - |
| Debt repayment | -58.05 Million | -52.51 Million | - | - | - |
| Dividends payments | -42.65 Million | -6.43 Million | -92.72 Million | - | - |
| Common Stock Repurchased | - | -15 Million | - | - | - |
| Common Stock Issuance | 76.5 Million | 70 Million | 4.2 Million | 57.15 Million | - |
| Other Financing Activities | -11.25 Million | - | - | 2.45 Million | - |
| Accounts receivables | -12.17 Million | - | - | - | - |
| Accounts payables | -36.25 Million | - | - | - | - |
| Inventory | 9.66 Million | -5.96 Million | 13.1 Million | 15.02 Million | - |
| Other working capital | -11.75 Million | - | - | - | - |
| Cash at beginning of period | 123.57 Million | 89.79 Million | 295.34 Million | 65.34 Million | - |
| Cash at end of period | 362.19 Million | 123.57 Million | 346.44 Million | 295.34 Million | - |
| Capital Expenditure | -46.23 Million | -2.59 Million | -9.79 Million | -1.7 Million | - |
| Effect of forex changes on cash | -678 Thousand | - | -399 Thousand | 30 Thousand | - |
| Net cash flow / Change in cash | 238.62 Million | 33.77 Million | 51.1 Million | 229.99 Million | - |
| Free Cash Flow | 9.74 Million | 39.99 Million | 150.96 Million | 180.15 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 35.71 Million | 35.71 Million | 5.32 Million | 54.27 Million | 2.5 Million | 39.06 Million |
| Depreciation & Amortization | 24.12 Million | 24.12 Million | 11.26 Million | 27.1 Million | 5.63 Million | 15.84 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | -2000.00 | - |
| Change in working capital | -34.07 Million | -34.07 Million | -13.94 Million | -14.26 Million | 11.83 Million | -2.04 Million |
| Other non-cash items | 15.76 Million | 15.76 Million | -4.79 Million | 585 Thousand | -19.43 Million | 3.55 Million |
| Investing Cash Flow | -30.35 Million | -30.35 Million | 259.67 Million | 218.77 Million | 129.83 Million | -40.89 Million |
| Investments in PPE | -25.24 Million | -25.24 Million | -11.25 Million | -46.23 Million | -5.62 Million | -34.98 Million |
| Acquisitions | - | - | - | 293.22 Million | 146.61 Million | - |
| Investment purchases | -1.39 Million | - | 4.8 Million | - | - | -4.8 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -5.11 Million | -5.11 Million | 266.12 Million | -28.21 Million | -11.14 Million | -2000.00 |
| Financing Cash Flow | -36.28 Million | -36.28 Million | 77.33 Million | -35.45 Million | 37.04 Million | -111.06 Million |
| Debt repayment | -2.07 Million | - | -54.81 Million | -58.05 Million | - | -1.51 Million |
| Dividends payments | -59.38 Million | -29.69 Million | -66.06 Million | -42.65 Million | - | -108.71 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 65.56 Million | 76.5 Million | - | 10.93 Million |
| Other Financing Activities | -6.58 Million | -6.58 Million | 518 Thousand | - | 37.04 Million | -11.76 Million |
| Accounts receivables | -18.87 Million | -18.87 Million | -12.55 Million | - | 2.42 Million | 388 Thousand |
| Accounts payables | 22.84 Million | - | -34.88 Million | - | - | -1.36 Million |
| Inventory | -23.62 Million | -23.62 Million | 11.3 Million | 9.66 Million | 5.65 Million | -1.64 Million |
| Other working capital | 8.42 Million | 8.42 Million | 22.19 Million | - | 3.76 Million | 581 Thousand |
| Cash at beginning of period | 362.19 Million | - | 282.22 Million | 123.57 Million | 173.71 Million | 377.78 Million |
| Cash at end of period | 312.15 Million | -25.01 Million | 362.19 Million | 362.19 Million | 340.8 Million | 282.22 Million |
| Capital Expenditure | -25.24 Million | -25.24 Million | -11.25 Million | -46.23 Million | -5.62 Million | -34.98 Million |
| Effect of forex changes on cash | 77 Thousand | 77 Thousand | - | -678 Thousand | -331 Thousand | - |
| Net cash flow / Change in cash | -50.03 Million | -25.01 Million | 79.96 Million | 238.62 Million | 167.09 Million | -95.56 Million |
| Free Cash Flow | 16.3 Million | 16.3 Million | -13.41 Million | 9.74 Million | -5.08 Million | 21.43 Million |
GOOGL
MEI
AMH
0040
603626
SUWN